Elizabeth Brém, MD
Associate Professor of Medicine
Division of Hematology/Oncology
Department of Medicine
School of Medicine
University of California Irvine Medical Center
Elizabeth Brém, MD, has disclosed that she has received consulting fees from Acrotech Biopharma and TG Therapeutics, is on the ad board for ADC Therapeutics and Kite, is on the speaker’s bureau for SeaGen, and is on the ad board and speaker’s bureau for BeiGene, Incyte, Janssen, MorphoSys, and Pharmacyclics.
Christopher R. Flowers, MD, MS
Department of Lymphoma/Myeloma, Division of Cancer Medicine
University of Texas MD Anderson Cancer Center
Christopher R. Flowers, MD, MS, has disclosed that he has received consultant fees from AstraZeneca, Bayer, BeiGene, Bioscend, BMS, Celgene, Curio Sciences, Denovo Biopharma, Epizyme/Incyte, Genentech/Roche, Genmab, MEI Pharmaceuticals, MorphoSys AG, Pharmacyclics/Janssen, and SeaGen and has received research funding from 4D, AbbVie, Acerta, Adaptimmune, Allogene, Amgen, Bayer, Celgene, Cellectis, EMD, Genentech/Roche, Gilead, Guardant, Iovance, Janssen, Kite, MorphoSys, Nektar, Novartis, Pfizer, Pharmacyclics, Sanofi, Takeda, TG Therapeutics, Xencor, and Ziopharm.